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Objective: Staphylococcus aureus (S. aureus) is a potent causative organism of septic arthritis. In this study, ciprofloxacin was used to nullify the 
bacterial burden in mice infected with pathogenic strain of S. aureus. Since, endogenous nitric oxide (NO) and prostaglandins (PG) are involved in 
several inflammatory diseases, in vivo modulation of their levels via Aminoguanidine (AMG) and Meclofenamic acid (MFA), in combination with 
ciprofloxacin, are used to modulate the inflammatory conditions in bacterial arthritis. 
ABSTRACT 
Methods: Septic arthritis were induced in mice by S. aureus (i. v.) infection followed by AMG or MFA treatment with ciprofloxacin. Mice were 
sacrificed at 3, 9 and 15 days post-infection (DPI). The clinical signs of septic arthritis were recorded, bacterial density determination in blood, 
spleen and synovial tissue, several biochemical, enzyme assays and histological studies of the synovial joint was performed.  
Results: AMG or MFA treatment alone does not lead to bacterial clearance since endogenous NO or PG was limited for bacterial killing. Ciprofloxacin 
treatment in combination with either AMG or MFA showed mitigation of bacterial burden as is evident from the CFU count and maximum reduction 
in inflammatory conditions, apparent from the reduced percentage of induction of septic arthritis, decreased myeloperoxidase (MPO), lysozyme 
activities, level of serum uric acid and creatinine as well as from the histological examinations. 
Conclusion: The combination treatment of ciprofloxacin along with immune modulators, AMG or MFA may lead to diminution of the inflammatory 
build up caused by S. aureus induced septic arthritis in mice. 
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INTRODUCTION 
Septic arthritis, an infectious arthritis, may represent a direct 
invasion of joint space by various microorganisms. Staphylococcus 
aureus
Thus, a variety of combination treatments to combat bacterial 
arthritis are also under investigation. It has been reported earlier 
that a major fall in the incidence of nosocomial infections can be 
achieved by focusing on adequate antibiotic prophylaxis, 
pretreatment and appropriate treatment of acute infections [7] S. 
aureus that can be treated with penicillin and methicillin, is called 
methicillin-susceptible S. aureus (MSSA). Unfortunately, some 
strains of S. aureus have become resistant to methicillin and other 
similar antibiotics [8]. These strains are known as Methicillin-
resistant S. aureus (MRSA), which cannot be cured with traditional 
penicillin-related drugs. Instead, MRSA must be treated with alternate 
antibiotics or with combination with immunomodulators [9]. 
 is the most common bacteria found in nongonococcal 
bacterial arthritis in humans. Human bacterial arthritis usually has a 
hematogenic spread (septic arthritis) and through circulation they 
reach the synovial tissue to seed in, colonize and promote tissue 
damage as S. aureus carries a wealth of pathogenic determinants (a 
wide variety of bacterial surface factors including the cell wall, 
capsular polysaccharides, collagen receptor, fibronectin binding 
protein and other exotoxins and endotoxins) [1] which evokes an 
intense host responses [2]. The bacterial evasion weapons and the 
counter-actions of host immune system produce inflammation and 
sepsis. The mechanisms of S. aureus induced sepsis are being studied 
and are still under investigation among which Toxic Shock 
Syndrome Toxin-1 (TSST-1) and the staphylococcal enterotoxins 
play vital role. They belong to the group of toxins known as 
Pyrogenic Toxin Superantigens (PTSAgs) [3]. The best characterized 
property of this group is superantigenicity, i.e. the ability of this 
toxin to stimulate proliferation of T-lymphocytes. These TSSTs cause 
tissue infiltration of neutrophils, macrophages and immunologically 
active cells which combat the pathogenic weapons by numerous 
proinflammatory substances (like nitric oxide and prostaglandins) 
and enzymes causing the progress of inflammation and ultimately 
sepsis, as in septic arthritis [4]. S. aureus is thereby responsible for 
serious invasive diseases and indeed is a leading cause of sepsis [5] 
Although, S.aureus is a highly efficient pathogen in causing septic 
arthritis, the precise role of cellular invasion in S. aureus pathology 
in vivo is still controversial [6] and requires extensive study to find 
out ways to effectively eradicate the bacterial burden from the 
tissues simultaneously to mitigate the inflammatory agony. 
Ciprofloxacin, a synthetic carboxyquinolone derivative, easily 
penetrates into tissues resulting in concentrations that exceed its 
corresponding serum levels [10]. This antibiotic which do not show 
plasmid-mediated resistance, has a broad spectrum of antibacterial 
activity and acts by inhibiting the A-subunit of DNA gyrase 
(topoisomerase) which is essential in the reproduction of bacterial 
DNA [11]. Thus, in this investigation ciprofloxacin is used to reduce 
bacterial burden. 
To ameliorate the inflammatory conditions, the focus should also be 
on the inhibition of basic proinflammatory substances. The 
endogenous key proinflammatory substances such as nitric oxide 
(NO) and prostaglandins (PG) possess the potential to stimulate 
severe inflammatory reactions [12]. Thus, aminoguanidine (AMG), 
an inhibitor of NO synthesis and meclofenamic acid (MFA), an 
inhibitor of PG production were used in this study. 
Therefore, treatment with antibiotic either alone or in combination 
with inhibitors of NO, PG might be effective in modulating septic 
arthritis. Thus, in this study, the role of ciprofloxacin in combination 
with either AMG or MFA, in modulation of S. aureus induced septic 
arthritis in mice was investigated. 
MATERIALS AND METHODS 
Animals 
Male Swiss albino mice, 6-8 weeks old, average body weight 20±4 
gm were used for all experiments. Upon arrival, mice were 
randomized into plastic cages with filter bonnets and saw dust 
bedding, followed by a one-week quarantine period. Mice were 
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housed 6 per cage with food and water ad libitum. Animal rooms 
were maintained at 21-24 oC and 40-60% humidity with a 12h light-
dark cycle. All experiments were approved by the Institutional 
Animal Ethical Committee (IAEC) [Proposal number: IAEC-
III/Proposal/Ph. D-URF/BB-03/2012 dated 24.07.2012]. 
Bacteria 
Pathogenic S. aureus strain (P-1490) was of the clinical isolate from 
NRS hospital at Kolkata. In each experiment, bacteria were cultured 
on nutrient agar for 24h at 37oC, inoculated into tryptic soy broth 
and incubated for another 15h. The organisms were collected by 
centrifugation and washed three times with 0.85% saline. The 
concentration of washed cells was adjusted spectrophotometrically at 
550 nm. The numbers of viable S. aureus cells were established by 
plating serial 10-fold dilutions of a bacterial solution in 0.01 M 
phosphate buffered saline (pH 7.4) on nutrient agar. Mice were injected 
intravenously, 106
Blood from each infected mice was plated on mannitol salt agar 
selective media. Spleen and synovial tissue were excised, weighed, 
homogenized, diluted in sterile saline and also plated on mannitol 
agar. Results were expressed as the number of bacterial CFU/ml of 
blood and per 100 mg of tissue [13]. 
 CFU/mouse of average body weight of 20g via the tail 
vein in 0.1 ml saline to each of the mice, grouped for each strain of S. 
aureus separately. Control mice received 0.1 ml of sterile saline through 
the tail vein. Bacterial colonies were routinely counted [13]. 
Survival rate study 
The mice were monitored daily. The number of mice which survived 
at different days post infection (DPI) was noted [13]. 
Treatment with antibiotics and immunomodulatory agents 
Mice were infected separately with different strains of S. aureus. S. 
aureus infection was followed by treatment with the antibiotic, 
Ciprofloxacin and some immunomodulatory agents, MFA (COX 2 
inhibitor) and AMG (iNOS inhibitor), either in single or in 
combination. Then mice were sacrificed at different DPI. 
Swelling of wrist and ankle joints, arthritic scoring 
Arthritic scoring was done according to Mal et al. [13]. Swelling of 
wrist and ankle joints was to determine the level of the 
inflammatory response in mice challenged with S. aureus. Before the 
experimentation, the paws of randomly selected and age matched 
mice were measured and the baseline paw size of the mice was 
determined. After infection, the mice paw diameter, wrist and ankle 
joints were measured every other day for 15 days with a dial-type 
vernier-calliper graduated 0.1 cm and the daily mean values were 
noted. This average value was used to infer the severity of swelling 
due to arthritis [14]. Percentage induction in arthritis per group of 
treated animals was calculated by considering the average paw 
diameter of the control group to be zero. 
Determination of numbers of viable S. aureus in blood, spleen 
and synovial tissue 
Serum uric acid level 
For the estimation, serum and double distilled water was taken in an 
agglutination tube. To it, 2/3(N) H2SO4 and 10% Na-tungstate was 
added. The mixture was allowed to precipitate for 10 minutes, 
filtered and marked as sample. 400μl uric acid were taken as 
standard and double distilled water was taken as blank in respective 
microtubes. Na2CO3
Serum creatinine level 
 and uric acid reagent were added in each 
microtubes and were allowed to stand for 15 minutes at room 
temperature. Then the OD was observed at 630 nm [15]. 
For the estimation, serum and double distilled water was take-in an 
agglutination tube. To it, 2/3(N) H2SO4
Synovial tissue Myeloperoxidase (MPO) assay 
It is an indicator of neutrophil infiltration. MPO activity was assayed 
spectrophotometrically [17]. 
Lysosyme assay: Assay was performed by taking Micrococcus 
lysodeikticus suspension in a cuvette and the reaction was started by 
adding synovial tissue homogenate from each group. The decrease 
in optical density at 450 nm was recorded as a function of time (3 
min). The change in absorbance for the first one minute was used to 
determine the enzyme activity [18]. 
Histopathological study 
Immediately after the sacrifice of the mice, whole knee joints were 
removed and fixed for 4 days in 10% formalin. After decalcification 
in 5% formic acid, all the specimens were processed for paraffin 
embedding and were sectioned. The tissue sections (7 µm) were 
stained with hematoxylin and eosin [19]. 
Statistical Analysis 
Results were expressed as mean±standard deviation (SD). 
Statistical analyses were performed using MS-Office Excel 2007 
software packages and one-way ANOVA followed by multiple 
comparison t-test to was done find out significant difference at 
P<0.05 or P<0.001 [20]. 
RESULTS 
 and 10% Na-tungstate were 
added. The mixture was allowed to precipitate for 10 minutes, 
filtered and later, taken as the sample. 200μl creatinine were taken 
as standard and double distilled water was taken as blank. Picric 
acid was added to all the tubes and was allowed to stand for 15 
minutes. Then, optical density (OD) was measured at 530 nm [16]. 
Experimental evaluation of arthritis: The induction of clinical 
arthritis, calculated from the mean diameters of the wrist and ankle 
joints of mice, was observed highest in the S. aureus infected group 
compared to the control group and was highest at 9 DPI which was 
49.35% that was seen to be ameliorated maximally in the 
ciprofloxacin, AMG or MFA co-treated groups, which were 10.53% 
and 10.38% respectively (table 1). 
 
Table 1: Effect of treatment of ciprofloxacin alone or in combination with immunomodulators on induction of septic arthritis after S. 
aureus infection in mice 
Groups Number of mice Number of mice died Paw diameter (mm) Induction of arthritis (%) 
Day 3 Day 9 Day 15 Day 3 Day 9 Day 15 
Control 6 0 2.74±0.021 3.08±0.016 3.08±0.013 0 0 0 
S. aureus 6 1 3.52±0.032 4.63±0.057 3.98±0.022 32.3 49.3 29.2 
Ci 6 0 3.13±0.049 3.45±0.081 3.09±0.009 15.9 12.2 3.0 
A 6 0 3.04±0.006 3.64±0.012 3.08±0.012 12.5 18.1 0 
M 6 0 3.08±0.011 3.58±0.034 3.09±0.014 14.0 16.1 0 
Ci+S 6 0 3.20±0.009 4.06±0.023 3.18±0.023 18.5 31.8 8.2 
Ci+A 6 0 2.83±0.007 3.64±0.024 3.12±0.028 5.0 16.8 1.2 
Ci+M 6 0 3.09±0.014 3.32±0.036 3.19±0.018 14.4 7.7 1.2 
S+A 6 0 3.17±0.012 3.48±0.022 3.28±0.023 17.4 12.9 6.4 
S+M 6 0 3.27±0.026 3.49±0.014 3.32±0.018 21.2 13.3 7.7 
Ci+S+A 6 0 3.00±0.064 3.31±0.021 3.13±0.091 14.4 10.5 1.6 
Ci+S+M 6 0 3.02±0.051 3.41±0.041 3.15±0.008 11.8 10.3 2.2 
Data of paw diameter are presented as the mean±SD, (n=6/group). Ci = Ciprofloxacin, A= Aminoguanidin, M = Meclofenamic acid, S = S. aureus 
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Effect of co-treatment with ciprofloxacin, AMG or MFA on viable 
bacteria number in the blood, spleen and synovial tissue of infected 
mice at different DPI: It has been observed after counting the colony 
from the mannitol salt agar plate that the CFU/ml of blood (fig. 1A) 
and CFU/100 mg of spleen (fig. 1B) in the bacteria challenged mice 
were highest at 3 DPI and the CFU/100 mg of synovial tissue (fig. 
1C) was highest at 9 DPI for pathogenic S. aureus and then cleared 
from blood and spleen at day 9 and 15 whereas from synovial tissue 
at day 15. When AMG or MFA alone was given after 2h of bacterial 
infection, bacterial burden was increased in blood and tissues on 3 
DPI compared to the non-treated S. aureus infected mice. Treatment 
with ciprofloxacin alone or in combination with either AMG or MFA 
after infection showed significant reduction in the CFU count in 
blood and spleen at 3 DPI while in synovial tissue at 3 and 9 DPI as 






Effect of co-treatment of ciprofloxacin, AMG or MFA in blood 
parameters of infected mice  
Serum uric acid level: Serum uric acid level of S. aureus alone infected 
mice was significantly higher than the control group and was found 
to be maximum at 9 DPI. Treatment of mice with ciprofloxacin, AMG 
or MFA alone after infection showed the significant reduction in 
serum uric acid level at 3, 9 and 15 DPI than S. aureus alone infected 
mice (P<0.05), but the maximum reduction was found in the group 
of mice co-administered with ciprofloxacin, AMG or MFA after being 
infected with S. aureus (P<0.05) (fig. 2A). 
 
 
Fig. 1: Effect of ciprofloxacin alone or in combination with 
immunomodulators on bacterial density in blood (A), spleen 
(B) and synovial tissue (C) of S. aureus infection induced septic 
arthritis. Data expressed as mean±SD (n=6/group); *control vs. 
S. aureus; **
 
S. aureus vs. combination treatment groups indicate 
significant difference at P<0.05; Ci=Ciprofloxacin, 
A=Aminoguanidin, M=Meclofenamic acid 
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Fig. 2: Effect of ciprofloxacin alone or in combination with 
immunomodulators on Serum uric acid (A) and creatinine (B) 
levels in S. aureus induced septic arthritis 
Values are mean±SD of 6 animals; *control vs. S. aureus; **S. 
aureus vs. treated groups; ***(S. aureus+Ci) vs. (S. aureus+Ci+A) 
&(S. aureus+Ci+M); ****
 
(S. aureus+A) or (S. aureus+M) vs. (S. 
aureus+Ci+A) or (S. aureus+Ci+M) indicate significant 
difference at P<0.05; Ci=Ciprofloxacin, A=Aminoguanidin, 
M=Meclofenamic acid 
Serum creatinine level: S. aureus infected mice showed significantly 
higher serum creatinine level of than the control group after 
infection at 3, 9 as well as 15 DPI. However, treatment of mice with 
ciprofloxacin or AMG or MFA alone after infection, significantly 
reduced the serum creatinine level and was further reduced by the 
combination treatment of ciprofloxacin with either AMG or MFA 
after infection than S. aureus alone infected mice (P<0.05) (fig. 2B). 
Synovial tissue myeloperoxidase (MPO) enzyme activity: The MPO 
activity is an indicator of neutrophil infiltration, was observed to be 
significantly elevated in the S. aureus infected group (P<0.05), on 3, 
9 and 15 DPI.  
When ciprofloxacin or AMG or MFA was administered alone 
following S. aureus infection, it produced significant reduction of 
tissue MPO activity but maximum diminution was found in the 
group of mice that co-treated with ciprofloxacin, AMG or MFA after 
S. aureus infection(P<0.05) (fig. 3A). 
Lysozyme activity (unit change) in the synovial tissue: Synovial tissue 
lysozyme activity in the S. aureus infected mice were significantly 
higher than the control group at 3, 9 and 15 DPI (P<0.05) and was 
highest at 9 DPI.  
The mice treated with ciprofloxacin or AMG or MFA alone after S. 
aureus infection showed the significant decrease in lysozyme activity 
but the utmost reduction in the same was found in the group that 
was treated with ciprofloxacin along with AMG or MFA after being 




Fig. 3: Effect of ciprofloxacin alone or in combination with 
immunomodulators on MPO (A) and lysozyme (B) enzyme 
activityin S. aureus induced septic arthritis 
Values are mean±SD of 6 animals; *control vs. S. aureus; **S. 
aureus vs. treated groups; ***(S. aureus+Ci) vs. (S. 
aureus+Ci+A)&(S. aureus+Ci+M); ****(S. aureus+A) or (S. 
aureus+M) vs. (S. aureus+Ci+A) or (S. aureus+Ci+M) indicate 
significant difference at P<0.05; Ci=Ciprofloxacin, 
A=Aminoguanidin, M=Meclofenamic acid 
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Histopathological analysis: Histological examination of the synovial 
joint showed pronouncedtissue degradation, erosion of bones and 
the articular cartilage as well as narrowing of joint spaces in the 
group only infected with S. aureus, while in the group treated with 
ciprofloxacin along with either AMG or MFA showed much less signs 
of synovitis (fig. 4).  
 
 
Fig. 4: Photomicrographs of paraffin-embedded H&E-stained 
mice knee-joint sections (400X) of control mice (A), treated 
with S. aureus (B),S. aureus and ciprofloxacin(C), S. aureus and 
AMG(D), S. aureus and MFA(E), S. aureus, ciprofloxacin and 




Modulations of induction of bacterial arthritis after co-
administration of ciprofloxacin either alone or in combination with 
AMG or MFA following exposure to S. aureus have been investigated 
in this study. Considering the impact of septic arthritis on human life 
and lack of comprehensive knowledge in its treatment with 
antibiotic and immunomodulators, makes this current study a 
relevant topic.  
The first perception of occurrence of septic arthritis may be the 
external manifestation of the same for which arthritic scoring was 
performed (from the paw diameter, swelling and redness of the 
joints of the mice) which depicted an increment in the arthritis 
induction in the group of mice that were infected with S. aureus 
alone relative to the control group. The scoring also unveils a visible 
low percentage of arthritis induction in the groups which received 
co-treatment of ciprofloxacin and AMG or MFA after S. aureus 
infection when compared with only infected group as well as with 
the infected group which received only ciprofloxacin treatment. As 
observed from the scoring results, the combination treatment of 
ciprofloxacin with AMG (which blocks endogenous NO synthesis by 
inhibition of iNOS)[21] or MFA (that blocks the synthesis of 
endogenous prostaglandin by inhibition of COX2)[22], may have 
been effective in ameliorating the clinical signs of inflammation due 
to S. aureus induced septic arthritis in mice. In this study, activities 
of iNOS and COX2 have been attempted to be blocked by the 
administration of AMG and MFA respectively. Since already 
innumerable copious experiments have been performed for years to 
show the effective inhibitory efficiency of the said compounds on the 
synthesis of NO and prostaglandins, it has not been determined in 
the present study. 
The clinical manifestations of inflammation may be well correlated 
with the bacterial burden in synovial tissue in time-dependent 
manner. The S. aureus infection was introduced in the mice via 
intravenous route and the bacterial density in terms of colony 
forming units (C. F. Us) was determined. In all the S. aureus infected 
groups (treated or untreated), the bacterial burden persists at 3 DPI 
but eventually gets cleared from blood at 9 DPI which may indicate 
that S. aureus might have migrated to the tissues in search of better 
‘homing’ [23]. The clearing of bacterial burden from spleen at 9 DPI 
may suggest the effective eradication of bacteria in presence of 
immense immunological active cells in the spleen. But, the 
persistence of S. aureus density and increase of the same at 9 DPI in 
synovial tissue perhaps deduces the synovial tissue, with its limited 
basement membrane and low fluid shear condition, to be the best 
choice for S. aureus to thrive in and colonise. The bacterial density 
was more in the group which received only S. aureus infection 
compared to the control group. The S. aureus infected group which 
received only AMG/MFA treatment showed even higher density of 
bacteria as compared to the group only infected by S. aureus, 
perhapsdepicting the anti-bacterial role of endogenous NO and 
prostaglandin, whose synthesis when blocked by administration of 
AMG (iNOS inhibitor) and MFA (COX2 inhibitor) respectively, leads 
to weakening of host immune defence to mitigate bacterial 
colonisation and growth. Whereas the groups treated by 
ciprofloxacin in combination with either AMG or MFA after being 
infected with S. aureus showed reduction in bacterial density 
compared to the only S. aureus infected group, probably leading to 
perceive that the combination treatment might have been potent in 
mitigation of bacterial burden to some extent. 
Serum uric acid and creatinine are the key clinical pointers of 
inflammation. Uric acid, the ‘pathogenic culprit’ promotes 
inflammation either by activity as endogenous adjuvant or by 
triggering interleukin-1β or via activation of the NOD-like receptor 
protein (NLRP), are still being studied [24]. In the same way, serum 
creatinine level is an indicator of tissue protein breakdown which 
may be an important sign to understand the progress of 
inflammation. In this study, both the serum uric acid and creatinine 
distinctly rise in the group that is being infected with S. aureus as 
compared to the control group predicting that the S. aureus infected 
group may have been suffering from critical inflammatory 
conditions. AMG or MFA, when administered alone in the S. aureus 
infected group, serum uric acid and creatinine were lowered than 
the only infected group and the infected group which received only 
ciprofloxacin; but, when administered with ciprofloxacin, the serum 
uric acid and creatinine were decreased nearly to control level. Thus, 
hindering the synthesis of endogenous NO and PG, the inflammatory 
severity may be beneficially modulated and, on combining this with 
the antibacterial activities of ciprofloxacin a better diminution in 
clinical parameters like serum uric acid and creatinine may be 
obtained. 
Significantly decreased activities of lysozyme and MPO in S. aureus 
infected synovial tissue and its amelioration after administration of 
AMG or MFA emphasises the anti-inflammatory role of 
immunomodulators. NO and PGs trigger infiltration of macrophages, 
neutrophils at the site of inflammation leading to lysozyme and MPO 
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activity to fight against bacterial survival worsening the septic 
scenario [25, 26]. The deterred lysozyme and MPO activity in 
synovial tissue may indicate that AMG or MFA and ciprofloxacin 
conceivably abate the inflammatory responses by minimising 
neutrophil infiltration into the synovial tissue and the S. aureus 
burden respectively. 
Thus, the S. aureus that had been injected through the tail vein of 
mice probably reached the synovial joints via the haematogenous 
route, grew themselves and triggered immune responses. This, in 
turn,presumably stimulated mast cells, complement system, 
macrophages along with other immune counterparts [27]. These 
activated cells might have released proinflammatory mediators like 
IFN-γ, TNF α, IL-6resulting in the activation of gene transcription 
factors such as NF-κβ, STAT1 etc [28] which could also be aroused 
via interaction of pathogens with Pattern Recognition Receptors or 
via the IgE immune complexes[27] which possibly could switch on 
COX2 and inducible NO synthase (iNOS) promoter.  
The activated i NOS with NADP+ and L-arginine might produce 
citrulline and NO. The interaction of host immune responses and 
bacterial components feasibly could propel Reactive Oxygen Species 
(ROS) [29]. These ROS along with NO might have produced 
peroxynitrite (ONOO-
Therefore, the findings of this investigation elucidates that the anti-
inflammatory traits of AMG or MFA may reduce the severity of 
inflammation caused in septic arthritis and, in turn, as the loss of 
inflammatory response may lead to a high bacterial burden in 
tissues, the antibacterial attributes of an effective antibiotic like 
ciprofloxacin may be used in combination with the immuno 
modulators which is likely be useful as remedial measure to 
eradicate this social menace in future. 
) and other Reactive Nitrogen Species (RNS). 
NO and RNS most likely could cause synovial tissue damages, 
narrowing of joint spaces, articular cartilage disruption, neutrophil 
migration into joint spaces, inflammation, as is evident from the 
results of this study. However, determination of oxidative changes in 
the inflammatory tissue might be performed for further detailing of 
the present study. Instead, the activated COX2 conceivably have 
produced prostaglandins from arachidonic acid augmenting vascular 
permeability thus permitting infiltration of neutrophils, lymphocytes 
and propagation of inflammatory conditions. 
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